Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma | 14 | 2023 | 1897 | 2.120 |
Why?
|
Lung Neoplasms | 24 | 2023 | 13102 | 2.040 |
Why?
|
Mesothelioma | 8 | 2022 | 818 | 2.020 |
Why?
|
Soft Tissue Neoplasms | 11 | 2022 | 1363 | 1.930 |
Why?
|
Peritoneal Neoplasms | 7 | 2022 | 665 | 1.840 |
Why?
|
Chondrosarcoma | 4 | 2023 | 309 | 1.800 |
Why?
|
Bone Neoplasms | 9 | 2023 | 2529 | 1.720 |
Why?
|
Fibrosarcoma | 4 | 2024 | 348 | 1.710 |
Why?
|
Sarcoma, Small Cell | 3 | 2022 | 22 | 1.600 |
Why?
|
Pleural Neoplasms | 6 | 2022 | 607 | 1.590 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 239 | 1.450 |
Why?
|
Hemangioendothelioma, Epithelioid | 2 | 2021 | 54 | 1.340 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2023 | 5221 | 1.250 |
Why?
|
Histiocytic Sarcoma | 2 | 2019 | 44 | 1.250 |
Why?
|
Immunohistochemistry | 18 | 2023 | 11366 | 1.110 |
Why?
|
Pleura | 2 | 2023 | 235 | 0.950 |
Why?
|
Luminescent Proteins | 5 | 2014 | 853 | 0.930 |
Why?
|
Neurofibrosarcoma | 1 | 2023 | 24 | 0.920 |
Why?
|
Solitary Fibrous Tumor, Pleural | 2 | 2019 | 25 | 0.870 |
Why?
|
Peritoneum | 2 | 2022 | 228 | 0.870 |
Why?
|
Solitary Fibrous Tumors | 1 | 2023 | 72 | 0.860 |
Why?
|
Osteoblastoma | 1 | 2022 | 24 | 0.830 |
Why?
|
RNA-Binding Protein EWS | 2 | 2021 | 216 | 0.820 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2021 | 35 | 0.810 |
Why?
|
Gene Fusion | 3 | 2022 | 371 | 0.800 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2022 | 73 | 0.800 |
Why?
|
NAD | 3 | 2017 | 593 | 0.780 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 388 | 0.780 |
Why?
|
Bone Cysts | 1 | 2021 | 47 | 0.780 |
Why?
|
Chordoma | 2 | 2023 | 359 | 0.770 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2022 | 116 | 0.760 |
Why?
|
Homeodomain Proteins | 4 | 2021 | 2421 | 0.760 |
Why?
|
Negative-Pressure Wound Therapy | 4 | 2024 | 150 | 0.760 |
Why?
|
Neurilemmoma | 2 | 2023 | 547 | 0.750 |
Why?
|
Cytosol | 3 | 2016 | 901 | 0.720 |
Why?
|
Transcription Factors | 9 | 2023 | 12208 | 0.710 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 175 | 0.710 |
Why?
|
Ubiquitin Thiolesterase | 6 | 2022 | 449 | 0.700 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 135 | 0.700 |
Why?
|
Diagnosis, Differential | 16 | 2022 | 12959 | 0.690 |
Why?
|
Humerus | 1 | 2021 | 266 | 0.680 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 381 | 0.670 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2019 | 61 | 0.670 |
Why?
|
Fibula | 1 | 2021 | 269 | 0.650 |
Why?
|
Hemangioma | 1 | 2023 | 738 | 0.640 |
Why?
|
Lipoma | 1 | 2020 | 334 | 0.610 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 380 | 0.610 |
Why?
|
Receptor, trkA | 1 | 2018 | 164 | 0.600 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2018 | 324 | 0.590 |
Why?
|
Myofibroma | 1 | 2017 | 50 | 0.590 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.590 |
Why?
|
Biosensing Techniques | 4 | 2014 | 668 | 0.590 |
Why?
|
Liposarcoma | 1 | 2020 | 333 | 0.590 |
Why?
|
Glycolysis | 4 | 2017 | 827 | 0.580 |
Why?
|
Osteosarcoma | 1 | 2022 | 881 | 0.580 |
Why?
|
Adenovirus E1A Proteins | 1 | 2016 | 76 | 0.570 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 188 | 0.560 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 594 | 0.550 |
Why?
|
In Situ Hybridization | 1 | 2020 | 1950 | 0.540 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 248 | 0.540 |
Why?
|
Neoplasm Proteins | 5 | 2022 | 3703 | 0.540 |
Why?
|
Scapula | 1 | 2017 | 164 | 0.530 |
Why?
|
WT1 Proteins | 1 | 2016 | 178 | 0.530 |
Why?
|
Salivary Gland Neoplasms | 1 | 2019 | 298 | 0.520 |
Why?
|
Neuroblastoma | 3 | 2018 | 1226 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2021 | 3597 | 0.520 |
Why?
|
Femur | 1 | 2021 | 1297 | 0.490 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2019 | 1660 | 0.490 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 575 | 0.490 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5853 | 0.460 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 340 | 0.460 |
Why?
|
Lung Diseases, Interstitial | 2 | 2019 | 808 | 0.460 |
Why?
|
Antigens, CD | 2 | 2021 | 4026 | 0.450 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 451 | 0.450 |
Why?
|
Carcinoma | 2 | 2022 | 2375 | 0.430 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 2938 | 0.430 |
Why?
|
Humans | 93 | 2024 | 744343 | 0.430 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1420 | 0.420 |
Why?
|
Lung | 8 | 2023 | 9856 | 0.390 |
Why?
|
Aged | 33 | 2023 | 163280 | 0.370 |
Why?
|
Epithelial Cells | 4 | 2021 | 3690 | 0.370 |
Why?
|
Fractures, Bone | 1 | 2022 | 1947 | 0.360 |
Why?
|
Protein Engineering | 1 | 2014 | 540 | 0.360 |
Why?
|
Chondroblastoma | 2 | 2020 | 50 | 0.360 |
Why?
|
Middle Aged | 36 | 2023 | 213383 | 0.350 |
Why?
|
Young Adult | 19 | 2023 | 56430 | 0.350 |
Why?
|
Radiology | 1 | 2023 | 2100 | 0.350 |
Why?
|
Molecular Imaging | 2 | 2014 | 828 | 0.340 |
Why?
|
Adult | 35 | 2024 | 214055 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2503 | 0.330 |
Why?
|
Mutation | 12 | 2022 | 29786 | 0.330 |
Why?
|
DNA-Binding Proteins | 4 | 2022 | 9648 | 0.330 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2023 | 624 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4034 | 0.330 |
Why?
|
Female | 43 | 2023 | 380194 | 0.320 |
Why?
|
Tumor Suppressor Proteins | 5 | 2022 | 2849 | 0.310 |
Why?
|
Male | 39 | 2023 | 350118 | 0.310 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.300 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2282 | 0.300 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2020 | 670 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4554 | 0.290 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6364 | 0.290 |
Why?
|
Prognosis | 11 | 2023 | 29063 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2019 | 318 | 0.290 |
Why?
|
Energy Metabolism | 1 | 2017 | 2899 | 0.280 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2376 | 0.270 |
Why?
|
Adolescent | 16 | 2023 | 85781 | 0.270 |
Why?
|
Aged, 80 and over | 16 | 2021 | 57776 | 0.250 |
Why?
|
Carcinoma, Papillary | 2 | 2021 | 783 | 0.240 |
Why?
|
Biopsy | 4 | 2020 | 6756 | 0.240 |
Why?
|
Octamer Transcription Factors | 1 | 2023 | 23 | 0.240 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2024 | 63 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2022 | 2649 | 0.220 |
Why?
|
Haploidy | 1 | 2022 | 136 | 0.220 |
Why?
|
Child | 13 | 2023 | 77709 | 0.210 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2022 | 1581 | 0.210 |
Why?
|
Mediastinum | 1 | 2023 | 267 | 0.210 |
Why?
|
Sarcoma, Synovial | 1 | 2023 | 167 | 0.210 |
Why?
|
Receptors, Steroid | 1 | 2022 | 155 | 0.210 |
Why?
|
Indocyanine Green | 1 | 2023 | 239 | 0.200 |
Why?
|
Thymoma | 1 | 2023 | 186 | 0.200 |
Why?
|
Cell Line, Tumor | 8 | 2023 | 16689 | 0.200 |
Why?
|
Acetonitriles | 1 | 2021 | 53 | 0.200 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.200 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4253 | 0.200 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2022 | 290 | 0.200 |
Why?
|
Pneumonia | 2 | 2023 | 2133 | 0.190 |
Why?
|
Repressor Proteins | 4 | 2022 | 3023 | 0.190 |
Why?
|
Thymus Neoplasms | 1 | 2023 | 268 | 0.190 |
Why?
|
Thoracic Diseases | 1 | 2021 | 97 | 0.190 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 182 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 99 | 0.180 |
Why?
|
Vulvar Neoplasms | 1 | 2022 | 272 | 0.180 |
Why?
|
Human papillomavirus 6 | 1 | 2019 | 16 | 0.180 |
Why?
|
Chondroma | 1 | 2020 | 58 | 0.180 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 38 | 0.180 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 284 | 0.180 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2021 | 190 | 0.170 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12072 | 0.170 |
Why?
|
Florida | 1 | 2020 | 435 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9239 | 0.170 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 267 | 0.160 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 450 | 0.160 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2018 | 120 | 0.160 |
Why?
|
Sirtuin 3 | 1 | 2018 | 68 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2019 | 220 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 294 | 0.150 |
Why?
|
Horses | 1 | 2018 | 304 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1114 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 260 | 0.150 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 75 | 0.150 |
Why?
|
Polymers | 2 | 2023 | 1621 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2021 | 506 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2023 | 8428 | 0.150 |
Why?
|
Hematologic Diseases | 1 | 2021 | 498 | 0.150 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 2187 | 0.150 |
Why?
|
Child, Preschool | 5 | 2023 | 41006 | 0.140 |
Why?
|
Thoracic Surgical Procedures | 1 | 2020 | 342 | 0.140 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1071 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2016 | 52 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 705 | 0.140 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1813 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.140 |
Why?
|
Paraganglioma | 1 | 2017 | 143 | 0.130 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 294 | 0.130 |
Why?
|
Gene Amplification | 1 | 2020 | 1063 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 332 | 0.130 |
Why?
|
src-Family Kinases | 1 | 2018 | 551 | 0.130 |
Why?
|
Cell Nucleus | 3 | 2020 | 2969 | 0.130 |
Why?
|
Pheochromocytoma | 1 | 2017 | 337 | 0.130 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2014 | 15 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 961 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 266 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 373 | 0.120 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2016 | 249 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2018 | 368 | 0.120 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2014 | 424 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2728 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2019 | 1880 | 0.120 |
Why?
|
Oncogene Proteins | 1 | 2018 | 749 | 0.120 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 611 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2948 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 689 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1692 | 0.120 |
Why?
|
Recurrence | 2 | 2022 | 8340 | 0.120 |
Why?
|
Piperazines | 2 | 2021 | 2488 | 0.110 |
Why?
|
Retrospective Studies | 13 | 2024 | 77449 | 0.110 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.110 |
Why?
|
DNA Helicases | 1 | 2018 | 859 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1209 | 0.110 |
Why?
|
Infant | 4 | 2023 | 35136 | 0.110 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3586 | 0.110 |
Why?
|
Pyruvic Acid | 1 | 2014 | 200 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4186 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1241 | 0.110 |
Why?
|
Neck | 1 | 2017 | 697 | 0.110 |
Why?
|
Genomics | 3 | 2022 | 5720 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14722 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 808 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2022 | 5172 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2174 | 0.100 |
Why?
|
Bone and Bones | 1 | 2022 | 2575 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4217 | 0.100 |
Why?
|
Lactic Acid | 2 | 2014 | 1133 | 0.100 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2017 | 740 | 0.100 |
Why?
|
Trans-Activators | 2 | 2022 | 2924 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2751 | 0.100 |
Why?
|
Calibration | 1 | 2014 | 816 | 0.100 |
Why?
|
Paclitaxel | 3 | 2023 | 1708 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2023 | 3479 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2948 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1905 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1587 | 0.090 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2023 | 273 | 0.090 |
Why?
|
Intracellular Space | 1 | 2011 | 212 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2749 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2011 | 2557 | 0.090 |
Why?
|
Mice | 10 | 2023 | 81183 | 0.090 |
Why?
|
Animals | 13 | 2023 | 168757 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11524 | 0.090 |
Why?
|
Neoplasms | 3 | 2023 | 21683 | 0.090 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1005 | 0.090 |
Why?
|
Influenza, Human | 1 | 2020 | 1479 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 2942 | 0.080 |
Why?
|
Archaeal Proteins | 1 | 2009 | 56 | 0.080 |
Why?
|
Fluorescent Dyes | 2 | 2023 | 1917 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10252 | 0.080 |
Why?
|
Adenosine Diphosphate | 1 | 2009 | 425 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2866 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
Workflow | 2 | 2022 | 847 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2020 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1903 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2011 | 3848 | 0.070 |
Why?
|
Cell Survival | 2 | 2014 | 5882 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2245 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5217 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.070 |
Why?
|
Platelet Count | 1 | 2008 | 781 | 0.070 |
Why?
|
Cell Line | 2 | 2017 | 15997 | 0.070 |
Why?
|
Genetic Engineering | 1 | 2011 | 951 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4838 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.060 |
Why?
|
Body Water | 1 | 2006 | 343 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 63114 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3647 | 0.060 |
Why?
|
Surgical Wound Infection | 2 | 2024 | 1540 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2183 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.060 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2022 | 36 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3772 | 0.050 |
Why?
|
Tumor Burden | 2 | 2019 | 1915 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 2025 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.050 |
Why?
|
Mesentery | 1 | 2022 | 205 | 0.050 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2022 | 202 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2023 | 11031 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1092 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9274 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10481 | 0.050 |
Why?
|
Porosity | 1 | 2022 | 362 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6895 | 0.050 |
Why?
|
Dairy Products | 1 | 2005 | 498 | 0.050 |
Why?
|
Protons | 2 | 2023 | 1127 | 0.050 |
Why?
|
Tropolone | 1 | 2021 | 10 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3616 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 751 | 0.050 |
Why?
|
Pancreatic Neoplasms | 2 | 2009 | 5256 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3462 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4262 | 0.050 |
Why?
|
Mitotic Index | 1 | 2020 | 172 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2009 | 1634 | 0.050 |
Why?
|
Skull Base | 1 | 2023 | 306 | 0.050 |
Why?
|
Gadolinium | 1 | 2005 | 952 | 0.050 |
Why?
|
Surgical Mesh | 1 | 2022 | 276 | 0.050 |
Why?
|
Epithelioid Cells | 1 | 2020 | 71 | 0.040 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2219 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 315 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 146 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 44 | 0.040 |
Why?
|
Water | 1 | 2005 | 1395 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2021 | 371 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1643 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2022 | 1878 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2021 | 934 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 25625 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1020 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2019 | 341 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2480 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1655 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2023 | 1094 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 986 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 713 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 19229 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 553 | 0.030 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.030 |
Why?
|
Fructosediphosphates | 1 | 2014 | 24 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2921 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1179 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3521 | 0.030 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2014 | 55 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1387 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2737 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3305 | 0.030 |
Why?
|
Cystectomy | 1 | 2019 | 686 | 0.030 |
Why?
|
Forecasting | 1 | 2023 | 2951 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2018 | 20822 | 0.030 |
Why?
|
Myocarditis | 1 | 2021 | 771 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 408 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 4011 | 0.030 |
Why?
|
Wound Healing | 1 | 2024 | 2785 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3327 | 0.030 |
Why?
|
Signal Transduction | 2 | 2016 | 23403 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2942 | 0.030 |
Why?
|
Models, Chemical | 1 | 2014 | 626 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3701 | 0.030 |
Why?
|
Sulfonamides | 1 | 2021 | 1938 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2043 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2265 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 1972 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2016 | 1185 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18029 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2077 | 0.020 |
Why?
|
Prostatectomy | 1 | 2019 | 1890 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
Histones | 1 | 2020 | 2599 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20129 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 401 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2825 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2014 | 1254 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2011 | 689 | 0.020 |
Why?
|
Pain | 1 | 2024 | 4986 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5102 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 40561 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4149 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4776 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.020 |
Why?
|
Mutagenesis | 1 | 2011 | 1266 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2203 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1484 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 380 | 0.020 |
Why?
|
Carrier State | 1 | 2009 | 518 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13881 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 854 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2009 | 1465 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2008 | 804 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11124 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2005 | 502 | 0.010 |
Why?
|
Glucose | 1 | 2014 | 4397 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39050 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2024 | 15295 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.010 |
Why?
|
Pedigree | 1 | 2009 | 4644 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6580 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6114 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2250 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 35421 | 0.010 |
Why?
|
Family | 1 | 2009 | 3147 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1774 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3966 | 0.010 |
Why?
|
Computer Simulation | 1 | 2006 | 6196 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5300 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9583 | 0.010 |
Why?
|